Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.

Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM.

Cancer Cell. 2008 Nov 4;14(5):382-93. doi: 10.1016/j.ccr.2008.10.005.

2.

Nuclear receptor COUP-TFII controls pancreatic islet tumor angiogenesis by regulating vascular endothelial growth factor/vascular endothelial growth factor receptor-2 signaling.

Qin J, Chen X, Yu-Lee LY, Tsai MJ, Tsai SY.

Cancer Res. 2010 Nov 1;70(21):8812-21. doi: 10.1158/0008-5472.CAN-10-0551. Epub 2010 Oct 26.

3.

Flt-1 regulates vascular endothelial cell migration via a protein tyrosine kinase-7-dependent pathway.

Lee HK, Chauhan SK, Kay E, Dana R.

Blood. 2011 May 26;117(21):5762-71. doi: 10.1182/blood-2010-09-306928. Epub 2011 Apr 1.

4.

MicroRNA-10 regulates the angiogenic behavior of zebrafish and human endothelial cells by promoting vascular endothelial growth factor signaling.

Hassel D, Cheng P, White MP, Ivey KN, Kroll J, Augustin HG, Katus HA, Stainier DY, Srivastava D.

Circ Res. 2012 Nov 9;111(11):1421-33. doi: 10.1161/CIRCRESAHA.112.279711. Epub 2012 Sep 5.

5.

Filamin B plays a key role in vascular endothelial growth factor-induced endothelial cell motility through its interaction with Rac-1 and Vav-2.

Del Valle-Pérez B, Martínez VG, Lacasa-Salavert C, Figueras A, Shapiro SS, Takafuta T, Casanovas O, Capellà G, Ventura F, Viñals F.

J Biol Chem. 2010 Apr 2;285(14):10748-60. doi: 10.1074/jbc.M109.062984. Epub 2010 Jan 28.

6.

Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes.

Ruan J, Luo M, Wang C, Fan L, Yang SN, Cardenas M, Geng H, Leonard JP, Melnick A, Cerchietti L, Hajjar KA.

Blood. 2013 Jun 27;121(26):5192-202. doi: 10.1182/blood-2013-03-490763. Epub 2013 Apr 30.

7.

Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin.

Komi Y, Suzuki Y, Shimamura M, Kajimoto S, Nakajo S, Masuda M, Shibuya M, Itabe H, Shimokado K, Oettgen P, Nakaya K, Kojima S.

Cancer Sci. 2009 Feb;100(2):269-77. doi: 10.1111/j.1349-7006.2008.01049.x.

8.

Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells.

Yamazaki M, Nakamura K, Mizukami Y, Ii M, Sasajima J, Sugiyama Y, Nishikawa T, Nakano Y, Yanagawa N, Sato K, Maemoto A, Tanno S, Okumura T, Karasaki H, Kono T, Fujiya M, Ashida T, Chung DC, Kohgo Y.

Cancer Sci. 2008 Jun;99(6):1131-8. doi: 10.1111/j.1349-7006.2008.00795.x. Epub 2008 Apr 14.

9.

SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.

Cao ZX, Zheng RL, Lin HJ, Luo SD, Zhou Y, Xu YZ, Zeng XX, Wang Z, Zhou LN, Mao YQ, Yang L, Wei YQ, Yu LT, Yang SY, Zhao YL.

Cell Physiol Biochem. 2011;27(5):565-74. doi: 10.1159/000329978. Epub 2011 Jun 15.

10.
12.

A natural anti-inflammatory enone fatty acid inhibits angiogenesis by attenuating nuclear factor-κB signaling in vascular endothelial cells.

Furuno A, Watari K, Nakamura M, Fukunaga Y, Jung JH, Ono M.

Int J Oncol. 2011 Feb;38(2):493-501. doi: 10.3892/ijo.2010.856. Epub 2010 Dec 3.

PMID:
21132269
13.

Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1.

Starzec A, Vassy R, Martin A, Lecouvey M, Di Benedetto M, Crépin M, Perret GY.

Life Sci. 2006 Nov 17;79(25):2370-81. Epub 2006 Aug 16.

PMID:
16959272
14.

A novel interleukin-17 receptor-like protein identified in human umbilical vein endothelial cells antagonizes basic fibroblast growth factor-induced signaling.

Yang RB, Ng CK, Wasserman SM, Kömüves LG, Gerritsen ME, Topper JN.

J Biol Chem. 2003 Aug 29;278(35):33232-8. Epub 2003 Jun 12.

15.

Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2.

Zhang L, Gasper WJ, Stass SA, Ioffe OB, Davis MA, Mixson AJ.

Cancer Res. 2002 Oct 1;62(19):5463-9.

16.

Downregulation of endothelial microRNA-200b supports cutaneous wound angiogenesis by desilencing GATA binding protein 2 and vascular endothelial growth factor receptor 2.

Chan YC, Roy S, Khanna S, Sen CK.

Arterioscler Thromb Vasc Biol. 2012 Jun;32(6):1372-82. doi: 10.1161/ATVBAHA.112.248583. Epub 2012 Apr 12.

17.

Regulation of vascular endothelial growth factor receptors by Rb and E2F1: role of acetylation.

Pillai S, Kovacs M, Chellappan S.

Cancer Res. 2010 Jun 15;70(12):4931-40. doi: 10.1158/0008-5472.CAN-10-0501. Epub 2010 Jun 1.

18.

microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.

Hu J, Cheng Y, Li Y, Jin Z, Pan Y, Liu G, Fu S, Zhang Y, Feng K, Feng Y.

Eur J Cancer. 2014 Sep;50(13):2336-50. doi: 10.1016/j.ejca.2014.06.005. Epub 2014 Jul 4.

PMID:
25001183
19.
20.

Overexpression of miRNA-497 inhibits tumor angiogenesis by targeting VEGFR2.

Tu Y, Liu L, Zhao D, Liu Y, Ma X, Fan Y, Wan L, Huang T, Cheng Z, Shen B.

Sci Rep. 2015 Sep 8;5:13827. doi: 10.1038/srep13827. Erratum in: Sci Rep. 2016;6:21221.

Supplemental Content

Support Center